Newsletter Subject

Could This Oil Name Make A Massive Move?

From

biotechbreakouts.com

Email Address

Kyle@Biotechbreakouts.com

Sent On

Tue, Apr 21, 2020 06:27 PM

Email Preheader Text

It’s Not Only Possible But Tonight At 8 PM ET You’ll Learn How Hello trader, Yesterday we

[Image] What If You Could Get Trader Like Returns From A Buy and Hold Portfolio? [Image]( It’s Not Only Possible But Tonight At 8 PM ET You’ll Learn How [Reserve Your Seat]( Hello trader, Yesterday we saw an unprecedented plummet in crude oil futures. The crude oil futures contracts that expired yesterday settled at -$37.63 per barrel. You read that right… those futures prices closed at negative territory. It’s something even the Wall Street veterans are scratching their heads and wondering about. Why did that happen? My Take On Negative Crude Oil Prices Well, those futures contracts were thinly traded and were set to expire. My take is that there is little to no demand for oil right now due to the coronavirus pandemic… so much so that a buyer of those contracts would have to pay someone to take the barrels of oil off their hands. That’s a signal to me that there is very little storage capacity out there as the glut of crude oil continues to rise. Not only that but negative oil prices cast a foreboding stormcloud that the coronavirus has damaged the economy. Of course, low crude oil prices would benefit consumers… but who’s really even driving a lot these days, minus the essential workforce? What I really think happened with oil prices yesterday was a “long squeeze”. Basically, the buyers of those contracts scrambled to get out because they didn’t want to take delivery of crude oil… so they just sold at any price they could get, leading to negative prices. What I Can Do With That Information Of course, you’re probably wondering, “Kyle, what does this all mean and how is it applicable to your trading?” Well, one piece of the puzzle is put together… but in order to [take advantage of this, I would need to find a potential play.]( For me, I love to look to my [Dollar Ace strategy]( to try to figure out where the smart money is placing their bets. One trade that came across my screen was a $461K bet in Energy Transfer LP (ET) — a diversified midstream energy company that transports, stores, and terminals oil and gas products. Why was this trade so interesting to me? Well, someone came in and purchase 2,000 July 20 $4 calls for about $2.30 per contract, when the stock price was around $6 a share. In other words, those were deep in-the-money (ITM) calls. [Why would someone buy the call options instead of buying shares of the stock outright?]( Leverage because they would’ve had to pay $1.2M to buy 200K shares of ET outright, but by purchasing those call options… they only had to pay a fraction of that, just $461K. Could the trader be looking for a massive move in ET… or do they know something that everyday traders don’t? Who knows… and only time will tell. There is an interesting chart setup in ET right now. If you look at the daily chart below ET, there’s a bull flag formation. [Image] From my experience, stocks typically breakout when it forms this pattern… and right now, there’s room all the way to about $8.50, and if ET breaks above that, it could potentially fill the gap. The thing is… I didn’t take this trade. Why? It simply didn’t fit into my trading system, but I found this setup so interesting that I needed to share it with someone. My trading system focuses on buying out-of-the-money (OTM) options that may look like wild bets to the untrained eye. [More specifically, I want to look for options priced under $1 that are set to expire worthless, unless there’s a catalyst.]( Of course, I could talk about how I’ve made a small fortune using my Dollar Ace trading system… However, I believe it can be more beneficial if I teach you how to find these trades, as I reveal in my [Dollar Ace Masterclass.]( [I believe it can open you up to a whole new world of trading opportunities.]( [Image] Kyle Dennis The People's Trader Remove me from Biotech Breakouts Free Newsletter [Click here to unsubscribe and stop receiving exclusive emails from kyle@biotechbreakouts.com]( Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative’s own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com. [Unsubscribe from all RagingBull Emails]( 62 Calef Hwy #233 Lee, New Hampshire 03861 United States

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.